周节透对乳头甲状腺癌复发的影响
概括
周节透 (PNI) 是乳头甲状腺癌 (PTC) 复发的重要预测因素. 识别PNI和瘤大小等相关因素对于治疗规划至关重要.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 甲状腺癌研究研究
背景情况:
- 局域性复发会影响多达28%的乳头甲状腺癌患者.
- 周节透 (PNI),瘤细胞通过淋巴结囊扩展,是一个新兴的危险因素.
- 在PTC中,PNI被认为是负预后指标.
研究的目的:
- 评估PNI在PTC复发中的预后意义.
- 确定在PNI患者中复发的预测因素.
主要方法:
- 对680名PTC患者进行了初始淋巴结转移 (ILNM) 的回顾性研究.
- 102名PNI阳性 (PNI+) 和122名PNI阴性 (PNI-) 患者的比较.
- 对与复发有关的人口和临床病理特征的统计分析.
主要成果:
- 复发率在PNI+患者 (40%) 和PNI-患者 (15%) 中显著更高.
- 多变量分析确定了PNI,中央ILNM和瘤大小 (TS) 作为复发的独立预后变量.
- 与复发相关的其他因素包括联合ILNM,阳性LN的数量,瘤阶段和sTg水平.
结论:
- PNI阳性是PTC复发的显著不良预后因素.
- PNI,特别是当与大瘤大小和中央ILNM相关时,应在治疗策略中考虑,包括放射性 (RAI) 治疗计划.
更多相关视频
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...